Discovery of Molecular DNA Methylation-Based Biomarkers through Genome-Wide Analysis of Response Patterns to BCG for Bladder Cancer

Background: Bacillus Calmette-Guérin (BCG) immunotherapy, the standard adjuvant intravesical therapy for some intermediate and most high-risk non-muscle invasive bladder cancers (NMIBCs), suffers from a heterogenous response rate. Molecular markers to help guide responses are scarce and currently no...

תיאור מלא

מידע ביבליוגרפי

Principais autores:	Dafina Ilijazi, Walter Pulverer, Iris E. Ertl, Ursula Lemberger, Shoji Kimura, Mohammad Abufaraj, David D’Andrea, Benjamin Pradere, Andreas Bruchbacher, Anna Graf, Francesco Soria, Martin Susani, Andrea Haitel, Luca Molinaro, Armin Pycha, Evi Comploj, Stephan Pabinger, Andreas Weinhäusel, Gerda Egger, Shahrokh F. Shariat, Melanie R. Hassler
פורמט:	Artigo
שפה:	Inglês
יצא לאור:	MDPI AG 2020-08-01
סדרה:	Cells
נושאים:	bladder cancer Bacillus Calmette-Guérin DNA methylation marker urothelial cancer Illumina MethylationEPIC BeadChip high-risk bladder cancer
גישה מקוונת:	https://www.mdpi.com/2073-4409/9/8/1839
תגים:	הוספת תג אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!